Redirecting to https://markets.businessinsider.com/news/stocks/quanta-therapeutics-announces-presentation-of-qtx3034-clinical-combination-data-with-anti-egfr-and-chemotherapy-in-colorectal-cancer-crc-at-esmo-and-fast-track-designation-for-patients-with-kras-1036638413